BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9655039)

  • 1. Association of cutaneous and oral diseases in HIV-infected men.
    Mirowski GW; Hilton JF; Greenspan D; Canchola AJ; MacPhail LA; Maurer T; Berger TG; Greenspan JS
    Oral Dis; 1998 Mar; 4(1):16-21. PubMed ID: 9655039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of skin disease in patients infected with human immunodeficiency virus in Bangkok, Thailand.
    Sivayathorn A; Srihra B; Leesanguankul W
    Ann Acad Med Singap; 1995 Jul; 24(4):528-33. PubMed ID: 8849182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology of skin diseases in HIV-infected patients: a prospective cohort study].
    Schaub N; Gilli L; Rufli T; Gyr N; Battegay M; Nüesch R; Itin P
    Praxis (Bern 1994); 1996 Sep; 85(38):1162-6. PubMed ID: 8927894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS.
    Glick M; Muzyka BC; Lurie D; Salkin LM
    Oral Surg Oral Med Oral Pathol; 1994 Apr; 77(4):344-9. PubMed ID: 8015797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral manifestations in 70 German HIV-infected women.
    Schmidt-Westhausen A; Grünewald T; Reichart PA; Pohle HD
    Oral Dis; 1997 May; 3 Suppl 1():S28-30. PubMed ID: 9456652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous findings in HIV-1-positive patients: a 42-month prospective study. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
    Smith KJ; Skelton HG; Yeager J; Ledsky R; McCarthy W; Baxter D; Turiansky GW; Wagner KF; Turianski G
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):746-54. PubMed ID: 7929920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatological findings correlated with CD4 lymphocyte counts in a prospective 3 year study of 1161 patients with human immunodeficiency virus disease predominantly acquired through intravenous drug abuse.
    Muñoz-Pérez MA; Rodriguez-Pichardo A; Camacho F; Colmenero MA
    Br J Dermatol; 1998 Jul; 139(1):33-9. PubMed ID: 9764146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Skin diseases disclosing human immunodeficiency virus infection in Mali].
    Mahé A; Bobin P; Coulibaly S; Tounkara A
    Ann Dermatol Venereol; 1997; 124(2):144-50. PubMed ID: 9740824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous manifestations of human immunodeficiency virus infection in Taiwan.
    Tzung TY; Yang CY; Chao SC; Lee JY
    Kaohsiung J Med Sci; 2004 May; 20(5):216-24. PubMed ID: 15233232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between cigarette smoking and selected HIV-related medical conditions.
    Conley LJ; Bush TJ; Buchbinder SP; Penley KA; Judson FN; Holmberg SD
    AIDS; 1996 Sep; 10(10):1121-6. PubMed ID: 8874629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucocutaneous manifestations in human immunodeficiency virus (HIV)-infected patients in Nouakchott, Mauritania.
    Boushab BM; Malick Fall FZ; Ould Cheikh Mohamed Vadel TK; Ould Cheikh Melaïnine ML; Maazouz MV; Savadogo M; Basco LK
    Int J Dermatol; 2017 Dec; 56(12):1421-1424. PubMed ID: 28960268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral manifestations of human immunodeficiency virus-infected patients in Taiwan.
    Chiang CP; Chueh LH; Lin SK; Chen MY
    J Formos Med Assoc; 1998 Sep; 97(9):600-5. PubMed ID: 9795527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of HIV-related oral manifestations in women: a review.
    Shiboski CH
    Oral Dis; 1997 May; 3 Suppl 1():S18-27. PubMed ID: 9456651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral findings in Mexican AIDS patients with cancer.
    Ramírez-Amador V; González M; de la Rosa E; Esquivel L; Volkow P; Ochoa FJ; Meneses A; Mohar A
    J Oral Pathol Med; 1993 Feb; 22(2):87-91. PubMed ID: 8445548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of oral lesions and their predictive value for progression of HIV disease.
    Begg MD; Lamster IB; Panageas KS; Mitchell-Lewis D; Phelan JA; Grbic JT
    Oral Dis; 1997 Sep; 3(3):176-83. PubMed ID: 9467362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinels and signposts: the epidemiology and significance of the oral manifestations of HIV disease.
    Greenspan JS
    Oral Dis; 1997 May; 3 Suppl 1():S13-7. PubMed ID: 9456650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatologic manifestations of HIV infection.
    Berger TG; Obuch ML; Goldschmidt RH
    Am Fam Physician; 1990 Jun; 41(6):1729-42. PubMed ID: 2190455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity, specificity, and positive predictive value of oral opportunistic infections in adults with HIV/AIDS as markers of immune suppression and viral burden.
    Patton LL
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Aug; 90(2):182-8. PubMed ID: 10936837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin manifestations in AIDS, HIV infection, and AIDS-related complex.
    Sindrup JH; Lisby G; Weismann K; Wantzin GL
    Int J Dermatol; 1987 Jun; 26(5):267-72. PubMed ID: 2956207
    [No Abstract]   [Full Text] [Related]  

  • 20. Histopathological study of cutaneous manifestations in HIV and AIDS patients.
    Rane SR; Agrawal PB; Kadgi NV; Jadhav MV; Puranik SC
    Int J Dermatol; 2014 Jun; 53(6):746-51. PubMed ID: 24320966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.